Clinical Trial Update: Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

View source ↗

Summary

The document provides a status update on an intermediate-size cohort Expanded Access Program (EAP) evaluating Ersodetug in patients with tumor-associated hyperi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor-associated Hyperinsulinism

Drugs mentioned

• Ersodetug (ersodetug)

Snippet

Sponsor: Rezolute | Conditions: Tumor-associated Hyperinsulinism (Tumor HI) | Status: AVAILABLE